HIMS

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.44
Percentage change 0.89	%

Peers: ELF LFMD PRGO TDOC GDRX AMWL DOCS CLOV RXRX TWST

| Held by: IJH VTI VB IWM VXF VBK IWO MDY XMHQ IJK

Scroll to Statements

Index	RUT	P/E	72.56	EPS (ttm)	0.69	Insider Own	14.81%	Shs Outstand	215.21M	Perf Week	18.75%
Market Cap	11.16B	Forward P/E	51.44	EPS next Y	0.97	Insider Trans	-6.22%	Shs Float	190.70M	Perf Month	-4.87%
Enterprise Value	10.90B	PEG	2.10	EPS next Q	0.15	Inst Own	70.31%	Short Float	32.35%	Perf Quarter	71.07%
Income	164.40M	P/S	6.25	EPS this Y	27.49%	Inst Trans	-4.34%	Short Ratio	1.37	Perf Half Y	77.09%
Sales	1.78B	P/B	20.29	EPS next Y	43.43%	ROA	24.54%	Short Interest	61.69M	Perf YTD	106.16%
Book/sh	2.46	P/C	34.58	EPS next 5Y	34.58%	ROE	36.79%	52W High	72.98 -31.69%	Perf Year	131.22%
Cash/sh	1.44	P/FCF	47.43	EPS past 3/5Y	- 17.22%	ROIC	27.00%	52W Low	13.47 270.08%	Perf 3Y	986.06%
Dividend Est.	-	EV/EBITDA	79.02	Sales past 3/5Y	75.77% -	Gross Margin	68.19%	Volatility	12.14% 9.41%	Perf 5Y	394.05%
Dividend TTM	-	EV/Sales	6.11	EPS Y/Y TTM	6218.70%	Oper. Margin	6.48%	ATR (14)	5.40	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.32	Sales Y/Y TTM	85.99%	Profit Margin	9.21%	RSI (14)	47.68	Recom	2.64
Dividend Gr. 3/5Y	- -	Current Ratio	1.59	EPS Q/Q	313.81%	SMA20	-7.06%	Beta	2.04	Target Price	46.27
Payout	0.00%	Debt/Eq	0.12	Sales Q/Q	110.67%	SMA50	1.16%	Rel Volume	0.80	Prev Close	49.41
Employees	1637	LT Debt/Eq	0.11	Earnings	May 05 AMC	SMA200	45.53%	Avg Volume	45.18M	Price	49.85
IPO	Sep 13, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	65.43% 8.80%	Trades		Volume	36,327,438	Change	0.89%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-23-25	Downgrade	Needham	Buy → Hold
Jun-04-25	Reiterated	Needham	Buy	$61 → $65
Apr-29-25	Downgrade	TD Cowen	Buy → Hold	$30
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10
Feb-09-23	Upgrade	Jefferies	Hold → Buy	$7 → $11
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$5

Show Previous Ratings

Today 10:11AM	Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside? (Zacks)
09:06AM	BRKR Stock Gains Following the Multi-System Advanced Packaging Order (Zacks)
08:49AM	Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock (Zacks)
08:30AM	SYK Boosts Foot & Ankle Portfolio With FDA-Cleared Total Ankle System (Zacks)
Jun-28-25 10:25AM	Hims & Hers (HIMS) Jumps 6.76% Anew as Investors Cheer Weight Loss Drug Fight (Insider Monkey)
06:00AM	Loading…
06:00AM	Hims & Hers' ugly split with Wegovy maker weighs on the telehealth company's future (LA Times)
Jun-27-25 02:22PM	Hims & Hers (HIMS) Rallies 11.76% as CEO Not Backing Down After Novo Nordisk Spat (Insider Monkey) +6.76%
07:59AM	Reasons to Add Align Technology Stock to Your Portfolio Now (Zacks)
07:58AM	Health & Fitness Stocks to Buy as the Wellness Trend Grows (Zacks)
07:30AM	Novo Nordisk teams up with WeightWatchers in latest telehealth push (Pharmaceutical Technology)
06:42AM	Weekly Recap: 12 Health Press Releases You Need to See (PR Newswire)
04:53AM	Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover? (Motley Fool)
04:51AM	Novo Nordisk says WeightWatchers will sell Wegovy (Reuters Videos)
03:27AM	Jim Cramer on Hims & Hers: "You Gotta Generate Some Discipline Here" (Insider Monkey)
Jun-26-25 08:33PM	This Weight Loss Partnership Was a Short One (Motley Fool) +11.76%
07:09PM	Loading…
07:09PM	Hims & Hers Health, Inc. (NYSE: HIMS) Accused of Illegal Mass Compounding and Deceptive Marketing Practices; Investors Urged to Contact Award-Winning Firm, Gibbs Mura (Business Wire)
03:50PM	Why Is Hims & Hers Health (HIMS) Stock Soaring Today (StockStory)
02:04PM	Stocks on the Move: Hims & Hers Health and JetBlue (CNBC TV)
01:21PM	Tesla exec. & Musk confidant reportedly ousted, US stocks rise (Yahoo Finance Video)
12:41PM	Novo Nordisk to Expand Access to Wegovy With WeightWatchers Partnership (The Wall Street Journal)
12:19PM	Micron slips, Meta & AI talent, Novo Nordisk & Weight Watchers (Yahoo Finance Video)
09:35AM	Hims & Hers Health (HIMS) Loses 22.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
08:07AM	Illumina Stock May Benefit From New Agreement to Acquire SomaLogic (Zacks)
Jun-25-25 02:20PM	General Mills earnings, Novo Nordisk stock slips, Micron results (Yahoo Finance Video)
02:08PM	Hims & Hers Health, Inc. (HIMS) Shares Crash After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy, Faces Investor Scrutiny- Hagens Berman (PR Newswire)
10:03AM	GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications (Zacks)
09:49AM	Hims Won't Back Down From Selling Cheap Weight-Loss Shots (Bloomberg)
09:07AM	Novo Nordisk split puts Hims & Hers future in question (Yahoo Finance)
09:00AM	Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:30AM	Carnival Cruises Past Market Expectations in Boon for Shares (The Daily Upside)
06:30AM	Loading…
06:30AM	AstraZeneca and Daiichi Sankyo Treatment Wins First of Its Kind FDA Blessing to Treat Lung Cancer (The Daily Upside)
Jun-24-25 05:50PM	The Weight Loss Drug Market Has Gotten Messy. What to Know. (Barrons.com)
04:32PM	Can Hims Recover after Novo Nordisk Diss? (Zacks)
02:05PM	Hims & Hers (HIMS) Slashes 34.6% as Novo Nordisk Terminates Partnership (Insider Monkey)
01:04PM	Novo Nordisk terminates collaboration with Hims & Hers Health (TipRanks)
01:03PM	Hims & Hers core revenue growth has slowed sharply, says BofA (TipRanks)
12:50PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:58AM	Compounding Crisis: Johnson Fistel's Probe into Hims & Hers' Semaglutide Scandal (Newsfile)
11:49AM	Hims & Hers Strengthens Its Footprint in Consumer-Driven Obesity Care (Zacks)
11:25AM	Can Novo Nordisk Regain Ground After Cutting Ties With Hims & Hers? (Zacks)
09:37AM	Zacks Investment Ideas feature highlights: Nasdaq 100 Index ETF, US Oil Fund ETF, Advanced Micro Devices, Tesla and Hims and Hers Health (Zacks)
09:33AM	Should You Continue to Retain Abbott Stock in Your Portfolio Now? (Zacks)
08:35AM	Is This the Right Time to Hold EYE Stock in Your Portfolio? (Zacks)
08:24AM	Why Hims & Hers Stock Could Be a Multi-Bagger in the Making (MarketBeat)
07:02AM	Trump Brokers Surprise Iran, Israel Cease-Fire. He's Winning Over the Fed, Too. (Barrons.com)
06:30AM	Why Did Hims and Hers Stock Crash on Monday? (Motley Fool)
05:51AM	Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know (Motley Fool)
12:01AM	Novo Nordisk Backs Away From Hims & Hers Partnership (The Daily Upside)
12:01AM	Markets Stay Relatively Calm as Fragile Ceasefire Deal Follows Missile Strikes (The Daily Upside)
12:01AM	Iranian Ceasefire Deal Rewards Market Optimism During Missile Strikes (The Daily Upside)
Jun-23-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors (Zacks) -34.63%
05:19PM	Stocks to Watch Recap: Exxon, Tesla, Hims, Northern Trust (The Wall Street Journal)
04:56PM	These Stocks Moved the Most Today: Tesla, Hims & Hers, Wolfspeed, Super Micro, Fiserv, Northrop, Northern Trust, and More (Barrons.com)
03:31PM	Novo Nordisk Just Axed Its Deal with Hims & Hers. Should You Buy the Dip in HIMS Stock? (Barchart)
03:17PM	Why Hims & Hers Health Stock Is Crashing Today (Motley Fool)
02:50PM	HIMS Stock Crashes 30% in a Day: Time to Buy the Dip? (Zacks)
02:17PM	Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup (The Wall Street Journal)
02:07PM	These Stocks Are Moving the Most Today: Tesla, Hims & Hers, Wolfspeed, Super Micro, Fiserv, Northrop, Northern Trust, and More (Barrons.com)
01:19PM	Hims & Hers Stock Drops 30% After Novo Nordisk Breakup (The Wall Street Journal)
01:10PM	Stocks to Watch Monday: Exxon, Tesla, Hims, Northern Trust (The Wall Street Journal)
12:37PM	NovoHims & Hers deal ends, Eli Lilly GLP-1 pill: What to know (Yahoo Finance Video)
12:18PM	Hims & Hers Stock Plunges 30% as Novo Nordisk Ends Partnership, Citing 'Illegal' Practices (Investopedia)
12:02PM	Medical Services Name Flirts With A Buy Point (Investor's Business Daily)
11:53AM	Top Stock Movers Now: Tesla, Hims & Hers, Wolfspeed, and More (Investopedia)
11:53AM	Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Collaboration (Barrons.com)
11:48AM	Stock Market Today: Dow Jones Rises, Tesla Surges; Hims Craters As Novo Nordisk Torpedoes Deal (Live Coverage) (Investor's Business Daily)
11:39AM	Hims & Hers stock plummets after Novo Nordisk ends Wegovy direct sales deal (Yahoo Finance)
11:32AM	Hims & Hers, healthcare stocks, BNY: Trending Tickers (Yahoo Finance Video)
11:20AM	Novo Nordisk Stock Sinks as Latest Weight-Loss Drug Trial Disappoints (Investopedia)
11:13AM	Hims & Hers Health (HIMS) Stock Trades Down, Here Is Why (StockStory)
10:07AM	Bulls Shrug Off Iran Strikes, Recover from Initial Oil Jolt (Zacks)
10:05AM	Hims & Hers' stock plunges. Here's why Wegovy parent ended its partnership with the company. (MarketWatch)
09:50AM	TNDM Stock Gains on t:slim X2's Compatibility With FreeStyle Libre 3 + (Zacks)
09:02AM	IBD 50's Hims Plummets After Novo Yanks Deal Over 'Deceptive' And 'Illegitimate' Wegovy Knockoffs (Investor's Business Daily)
08:36AM	Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership (Barrons.com)
08:24AM	Hims & Hers stock falls after Novo Nordisk ends weight loss drug pact (Investing.com)
Jun-20-25 12:49PM	How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl (Investor's Business Daily) +5.16%
Jun-19-25 12:09PM	Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now? (Zacks)
08:35AM	QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its Stock (Zacks)
08:18AM	ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise? (Zacks)
08:17AM	Should You Add NVST Stock to Your Portfolio Right Now? (Zacks)
08:09AM	How IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl (Investor's Business Daily)
Jun-18-25 10:30AM	Where Will Hims & Hers Stock Be in 10 Years? (Motley Fool)
09:22AM	Reasons to Add PAHC Stock to Your Portfolio Right Now (Zacks)
08:30AM	Bet on Winning DuPont Analysis & Pick 3 Top Stocks (Zacks)
08:28AM	Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge? (Zacks)
04:20AM	Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth) (Motley Fool)
Jun-17-25 08:39AM	DGX Stock Up on New Blood Test Development Deal With MD Anderson (Zacks)
Jun-16-25 04:00PM	These 2 Growth Stocks Are No-Brainer Buys Right Now (Motley Fool) +7.75%
11:19AM	GEHC Stock Declines Despite Expansion in Precision Care Capabilities (Zacks)
08:27AM	QGEN Stock Rises in After Market Following Partnership With Incyte (Zacks)
08:25AM	Should You Hold Myriad Genetics Stock in Your Portfolio Right Now? (Zacks)
06:20AM	Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar? (Zacks)
Jun-13-25 12:13PM	Should You Add QIAGEN Stock to Your Portfolio for Now? (Zacks)
09:00AM	Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jun-12-25 10:36AM	HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth (Zacks)
12:01AM	3 Reasons We Love Hims & Hers Health (HIMS) (StockStory)
Jun-11-25 09:32AM	Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to (Yahoo Finance)
08:35AM	Should You Continue to Hold Prestige Consumer Stock in Your Portfolio? (Zacks)
Jun-10-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Boughton Soleil	Officer	Jun 30 '25	Proposed Sale	50.50	2,572	129,886		Jun 30 10:56 AM
Okupe Oluyemi	Chief Financial Officer	Jun 23 '25	Sale	47.25	23,107	1,091,766	63,222	Jun 24 04:31 PM
Oluyemi Okupe	Officer	Jun 23 '25	Proposed Sale	41.98	69,431	2,914,713		Jun 23 04:49 PM
Chi Michael	Chief Commercial Officer	Jun 17 '25	Sale	59.75	17,102	1,021,844	278,654	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Option Exercise	2.43	125,335	304,564	285,550	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.76	128,127	7,271,950	160,215	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 17 '25	Sale	59.22	65,110	3,855,542	95,105	Jun 17 08:07 PM
Dudum Andrew	Chief Executive Officer	Jun 16 '25	Sale	56.51	47,534	2,686,300	237,660	Jun 17 08:07 PM
Boughton Soleil	Chief Legal Officer	Jun 16 '25	Sale	56.80	5,451	309,617	165,881	Jun 17 08:06 PM
Boughton Soleil	Chief Legal Officer	Jun 17 '25	Sale	59.75	2,572	153,677	163,309	Jun 17 08:06 PM
Becklund Irene	PAO	Jun 17 '25	Sale	59.75	8,485	506,979	712	Jun 17 08:06 PM
Chi Michael	Officer	Jun 17 '25	Proposed Sale	59.75	17,102	1,021,844		Jun 17 12:42 PM
Dudum Andrew	Officer	Jun 17 '25	Proposed Sale	59.22	65,110	3,855,544		Jun 17 12:13 PM
Becklund Irene	Officer	Jun 17 '25	Proposed Sale	59.75	8,485	506,979		Jun 17 11:19 AM
Boughton Soleil	Officer	Jun 17 '25	Proposed Sale	59.75	2,572	153,677		Jun 17 10:20 AM
Melissa Baird	Officer	Jun 16 '25	Proposed Sale	59.78	33,333	1,992,647		Jun 16 05:58 PM
Dudum Andrew	Officer	Jun 16 '25	Proposed Sale	56.49	47,534	2,685,348		Jun 16 02:42 PM
Boughton Soleil	Officer	Jun 16 '25	Proposed Sale	56.80	5,451	309,617		Jun 16 11:53 AM
Dudum Andrew	Officer	Jun 16 '25	Proposed Sale	56.43	128,127	7,230,643		Jun 16 11:24 AM
Chi Michael	Chief Commercial Officer	Jun 10 '25	Option Exercise	6.82	5,400	36,828	261,980	Jun 11 08:09 PM
Chi Michael	Chief Commercial Officer	Jun 10 '25	Sale	57.00	5,600	319,200	256,380	Jun 11 08:09 PM
Chi Michael	Officer	Jun 10 '25	Proposed Sale	57.00	5,400	307,800		Jun 10 12:12 PM
Chi Michael	Chief Commercial Officer	Jun 05 '25	Option Exercise	13.90	28,776	399,986	256,580	Jun 09 04:58 PM
Chi Michael	Chief Commercial Officer	Jun 06 '25	Option Exercise	13.20	5,100	67,335	260,180	Jun 09 04:58 PM
Chi Michael	Chief Commercial Officer	Jun 06 '25	Sale	56.00	5,100	285,600	256,580	Jun 09 04:58 PM
Chi Michael	Officer	Jun 06 '25	Proposed Sale	56.00	5,100	285,600		Jun 06 01:19 PM
Melissa Baird	Officer	Jun 04 '25	Proposed Sale	53.61	33,333	1,786,982		Jun 04 04:46 PM
Okupe Oluyemi	Chief Financial Officer	May 28 '25	Option Exercise	5.01	6,437	32,249	120,253	May 30 04:28 PM
Okupe Oluyemi	Chief Financial Officer	May 28 '25	Sale	52.98	11,581	613,537	39,153	May 30 04:28 PM
Boughton Soleil	Chief Legal Officer	May 27 '25	Sale	55.87	3,233	180,628	153,194	May 29 05:56 PM
Becklund Irene	PAO	May 22 '25	Sale	53.51	5,071	271,349	0	May 27 04:59 PM
Melissa Baird	Officer	May 27 '25	Proposed Sale	53.36	33,333	1,778,649		May 27 04:44 PM
Boughton Soleil	Officer	May 27 '25	Proposed Sale	55.87	3,233	180,628		May 27 11:12 AM
Becklund Irene	Officer	May 22 '25	Proposed Sale	53.51	5,071	271,349		May 22 09:45 AM
Okupe Oluyemi	Chief Financial Officer	May 15 '25	Option Exercise	10.97	6,437	70,646	125,397	May 19 06:35 PM
Okupe Oluyemi	Chief Financial Officer	May 15 '25	Sale	60.22	11,581	697,462	113,816	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Option Exercise	2.43	125,335	304,564	197,645	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Sale	58.40	128,127	7,482,414	89,311	May 19 06:35 PM
Dudum Andrew	Chief Executive Officer	May 16 '25	Sale	58.25	47,534	2,768,974	285,194	May 19 06:35 PM
Dudum Andrew	Officer	May 16 '25	Proposed Sale	58.36	175,661	10,251,390		May 16 11:08 AM
Baird Melissa	Chief Operating Officer	May 12 '25	Option Exercise	2.43	33,333	80,999	838,416	May 13 05:07 PM
Baird Melissa	Chief Operating Officer	May 12 '25	Sale	56.02	33,333	1,867,376	805,083	May 13 05:07 PM
Boughton Soleil	Chief Legal Officer	May 12 '25	Sale	56.00	3,235	181,160	156,427	May 13 05:07 PM
Melissa Baird	Officer	May 12 '25	Proposed Sale	55.21	33,333	1,840,315		May 12 05:10 PM
Boughton Soleil	Officer	May 12 '25	Proposed Sale	56.00	3,235	181,160		May 12 10:25 AM
Boughton Soleil	Chief Legal Officer	Apr 28 '25	Sale	30.19	3,236	97,695	159,662	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 29 '25	Option Exercise	2.43	50,000	121,500	142,103	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 28 '25	Option Exercise	2.43	41,667	101,251	133,770	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 29 '25	Sale	36.39	50,000	1,819,310	92,103	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 28 '25	Sale	30.19	41,667	1,257,760	92,103	Apr 30 06:01 PM
Dudum Andrew	Officer	Apr 29 '25	Proposed Sale	36.39	50,000	1,819,309		Apr 29 10:51 AM
Dudum Andrew	Officer	Apr 28 '25	Proposed Sale	30.19	41,667	1,257,753		Apr 28 12:51 PM
Boughton Soleil	Officer	Apr 28 '25	Proposed Sale	30.19	3,236	97,695		Apr 28 10:07 AM
Baird Melissa	Chief Operating Officer	Apr 21 '25	Option Exercise	1.97	33,333	65,653	838,416	Apr 23 04:21 PM
Baird Melissa	Chief Operating Officer	Apr 21 '25	Sale	25.78	33,333	859,256	805,083	Apr 23 04:21 PM
Becklund Irene	PAO	Apr 22 '25	Sale	26.49	2,936	77,775	5,071	Apr 23 04:21 PM
Becklund Irene	Officer	Apr 22 '25	Proposed Sale	26.49	2,936	77,775		Apr 22 09:46 AM
Melissa Baird	Officer	Apr 21 '25	Proposed Sale	25.84	33,333	861,325		Apr 21 04:37 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Option Exercise	2.43	33,668	81,813	128,563	Apr 18 03:40 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Sale	28.23	47,534	1,342,094	332,728	Apr 18 03:40 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Sale	28.04	36,460	1,022,453	92,103	Apr 18 03:40 PM
Boughton Soleil	Chief Legal Officer	Mar 03 '25	Sale	45.14	4,151	187,376	166,134	Apr 16 04:30 PM
Boughton Soleil	Chief Legal Officer	Apr 14 '25	Sale	28.72	3,236	92,938	162,898	Apr 16 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Apr 15 '25	Option Exercise	6.43	6,437	41,377	130,541	Apr 16 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Apr 15 '25	Sale	28.50	11,581	330,082	118,960	Apr 16 04:30 PM
Dudum Andrew	Officer	Apr 16 '25	Proposed Sale	28.15	83,994	2,364,547		Apr 16 10:44 AM
Boughton Soleil	Officer	Apr 14 '25	Proposed Sale	28.72	3,236	92,938		Apr 14 09:52 AM
Baird Melissa	Chief Operating Officer	Apr 09 '25	Option Exercise	1.75	33,337	58,340	838,420	Apr 10 04:30 PM
Baird Melissa	Chief Operating Officer	Apr 09 '25	Sale	27.32	33,337	910,687	805,083	Apr 10 04:30 PM
Melissa Baird	Officer	Apr 09 '25	Proposed Sale	29.49	33,337	983,108		Apr 09 04:42 PM
Baird Melissa	Chief Operating Officer	Apr 04 '25	Option Exercise	5.01	40,380	202,304	805,083	Apr 07 04:15 PM
Becklund Irene	PAO	Apr 03 '25	Sale	28.78	2,203	63,402	8,007	Apr 04 04:52 PM
Okupe Oluyemi	Chief Financial Officer	Apr 02 '25	Option Exercise	5.01	6,437	32,249	135,685	Apr 04 04:52 PM
Okupe Oluyemi	Chief Financial Officer	Apr 02 '25	Sale	29.26	11,581	338,833	124,104	Apr 04 04:52 PM
Becklund Irene	Officer	Apr 03 '25	Proposed Sale	28.78	2,203	63,402		Apr 03 10:29 AM
Baird Melissa	Chief Operating Officer	Mar 31 '25	Option Exercise	5.01	13,460	67,435	764,703	Apr 01 04:57 PM
Boughton Soleil	Chief Legal Officer	Mar 31 '25	Sale	27.77	3,236	89,864	170,285	Apr 01 04:57 PM
Boughton Soleil	Officer	Mar 31 '25	Proposed Sale	27.77	3,236	89,864		Mar 31 09:54 AM
Baird Melissa	Chief Operating Officer	Mar 26 '25	Option Exercise	0.40	67,687	27,075	818,930	Mar 27 05:04 PM
Baird Melissa	Chief Operating Officer	Mar 26 '25	Sale	34.84	67,687	2,358,145	751,243	Mar 27 05:04 PM
Melissa Baird	Officer	Mar 26 '25	Proposed Sale	33.36	67,687	2,258,038		Mar 26 04:09 PM
Okupe Oluyemi	Chief Financial Officer	Mar 21 '25	Sale	32.41	23,118	749,176	129,248	Mar 24 04:35 PM
Oluyemi Okupe	Officer	Mar 21 '25	Proposed Sale	34.75	69,442	2,413,110		Mar 21 05:00 PM
Carroll Patrick Harrison	Chief Medical Officer	Mar 18 '25	Sale	34.31	23,287	798,977	209,661	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Option Exercise	2.43	125,335	304,564	226,447	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.98	128,127	4,353,124	173,655	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 18 '25	Sale	33.85	78,760	2,666,199	94,895	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.64	47,534	1,599,170	380,262	Mar 18 06:35 PM
Boughton Soleil	Chief Legal Officer	Mar 18 '25	Sale	34.31	3,236	111,027	173,521	Mar 18 06:35 PM
Becklund Irene	PAO	Mar 18 '25	Sale	34.31	8,277	283,984	10,210	Mar 18 06:34 PM
Dudum Andrew	Officer	Mar 18 '25	Proposed Sale	33.85	78,760	2,666,200		Mar 18 12:24 PM
Boughton Soleil	Officer	Mar 18 '25	Proposed Sale	34.31	3,236	111,027		Mar 18 10:56 AM
Carroll Patrick Harrison	Officer	Mar 18 '25	Proposed Sale	34.31	23,287	798,977		Mar 18 10:52 AM
Becklund Irene	Officer	Mar 18 '25	Proposed Sale	34.31	8,277	283,984		Mar 18 10:24 AM
Dudum Andrew	Officer	Mar 17 '25	Proposed Sale	33.89	175,661	5,952,296		Mar 17 03:26 PM
Becklund Irene	PAO	Mar 11 '25	Sale	34.77	2,203	76,598	2,203	Mar 13 04:31 PM
Becklund Irene	Officer	Mar 11 '25	Proposed Sale	34.77	2,203	76,598		Mar 11 10:03 AM
Becklund Irene	PAO	Mar 03 '25	Sale	45.14	2,913	131,493	4,406	Mar 05 04:42 PM
Pendarvis Christiane	Director	Mar 05 '25	Proposed Sale	40.00	12,500	500,000		Mar 05 11:40 AM
Becklund Irene	Officer	Mar 03 '25	Proposed Sale	45.14	2,913	131,493		Mar 03 11:59 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Hims & Hers Health Inc

Upgrade your FINVIZ experience